SCHEMBL2456038

SCHEMBL2456038

CCON=C(C(=O)O)c1nsc(N)n1

nearest known ligand 0.35

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.35
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 1/20 0.31
LMNA P02545 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3833505 1.00 KCNH2 (0.35) KCNH2ALDH1A1MEN1NPC1MAPT
SCHEMBL3833502 1.00 KCNH2 (0.35) KCNH2ALDH1A1MEN1NPC1MAPT
SCHEMBL10773963 0.90 KCNH2 (0.36) KCNH2ALDH1A1MEN1NPC1MAPT
SCHEMBL10332929 0.90 KCNH2 (0.36) KCNH2ALDH1A1MEN1NPC1MAPT
SCHEMBL10837303 0.89 ALDH1A1 (0.33) KCNH2ALDH1A1LMNAHPGD
SCHEMBL9779227 0.89 ALDH1A1 (0.33) KCNH2ALDH1A1LMNAHPGD
SCHEMBL9779233 0.89 ALDH1A1 (0.33) KCNH2ALDH1A1LMNAHPGD
SCHEMBL10782782 0.88 ALDH1A1 (0.35) KCNH2ALDH1A1MEN1NPC1MAPT
SCHEMBL10782787 0.88 ALDH1A1 (0.35) KCNH2ALDH1A1MEN1NPC1MAPT
Hydrochloric Acid SCHEMBL8763432 0.87 KCNH2 (0.35) KCNH2ALDH1A1MEN1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4585872-A CEPHALOSPORIN ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-29 US claimed
EP-0036673-B1 NEW THIADIAZOL COMPOUNDS AND PROCESSES FOR THEIR PREPARATION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-07-11 EP claimed
JP-2076865-A None JP disclosed
CN-121181573-B Cephalosporium containing C-3 tetrahydrofuran derivative and application thereof 重庆汉佩生物科技有限公司 2026-02-27 CN disclosed
US-20140350240-A1 PROCESS FOR PREPARING CEFTAROLINE SALTS OR HYDRATES THEREOF RANBAXY LABORATORIES LIMITED (IN) 2014-11-27 US disclosed
EP-2788361-A1 PROCESS FOR PREPARING CEFTAROLINE SALTS OR HYDRATES THEREOF Ranbaxy Laboratories Limited (IN) 2014-10-15 EP disclosed
WO-2013084171-A1 PROCESS FOR PREPARING CEFTAROLINE SALTS OR HYDRATES THEREOF RANBAXY LABORATORIES LIMITED (IN) 2013-06-13 WO disclosed
US-8445476-B2 Carbacephem β-lactam antibiotics ACHAOGEN, INC. (US) 2013-05-21 US disclosed
US-20110224186-A1 CARBACEPHEM BETA-LACTAM ANTIBIOTICS ACHAOGEN, INC. (US) 2011-09-15 US disclosed
WO-2010123997-A1 CARBACEPHEM BETA-LACTAM ANTIBIOTICS ACHAOGEN, INC. (US) 2010-10-28 WO disclosed
US-20100267686-A1 CARBACEPHEM BETA-LACTAM ANTIBIOTICS ACHAOGEN, INC. (US) 2010-10-21 US disclosed
EP-0062321-A2 New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-10-13 EP disclosed
US-4338313-A CEPHALOSPORIN ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-07-06 US disclosed
US-4332800-A BACTERICIDES CONTAINING 7-AMINOTHIADIAZOLE GROUPS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-06-01 US disclosed
EP-0042154-A1 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-12-23 EP disclosed
EP-0036673-A1 New thiadiazol compounds and processes for their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-09-30 EP disclosed
US-4268509-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-05-19 US disclosed
EP-0027599-A2 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-04-29 EP disclosed
EP-0013762-A2 Cephem and cepham compounds, processes for their preparation, pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-08-06 EP disclosed
EP-0007470-A2 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224186-A1 CARBACEPHEM BETA-LACTAM ANTIBIOTICS MGAM, MGAM2, B2M KCNH2 3039/4885ALDH1A1 2455/4885MEN1 2327/4885
US-20100267686-A1 CARBACEPHEM BETA-LACTAM ANTIBIOTICS MGAM, MGAM2, B2M KCNH2 3205/4885ALDH1A1 2468/4885MEN1 2194/4885
US-20140350240-A1 PROCESS FOR PREPARING CEFTAROLINE SALTS OR HYDRATES THEREOF CYP3A7, SEPTIN7, UGT1A7 KCNH2 969/4885ALDH1A1 2155/4885MEN1 2102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.